Author Correction: LncRNA CASC2 inhibits cell proliferation, metastasis and EMT through miR-18a/SOCS5 axis in cholangiocarcinoma
L. Peng, Y.-H. Liu, S. Nie, M. Gao Department of Pediatrics, The First Hospital of Jilin University, Changchun City, Jilin Province, China
Correction to: European Review for Medical and Pharmacological Sciences 2020; 24 (16): 8367-8376–DOI: 10.26355/eurrev_202008_22633–PMID: 32894543, published online 31 August, 2020.
The authors state that “the segment of Figure 2C (si-RNA-NC) was used twice due to a careless mistake during the preparation of Figure 2”.
There are amendements to this paper. The Publisher apologizes for any inconvenience this may cause.
https://www.staging.europeanreview.org/article/22633
Free PDF Download![Creative Commons License](https://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
L. Peng, Y.-H. Liu, S. Nie, M. Gao
Author Correction: LncRNA CASC2 inhibits cell proliferation, metastasis and EMT through miR-18a/SOCS5 axis in cholangiocarcinoma
Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 4
Pages: 1767-1767
DOI: 10.26355/eurrev_202102_25056